Highmark Health remained financially strong in 2022, reporting $26 billion in consolidated revenue, an operating gain of $440 million, and a net loss of $346 million. Excluding unrealized investment impact, the organization reported net earnings of roughly $47 million for 2022. As of December 31, 2022, the organization had $11 billion in cash and investments and net assets of $9 billion.
This strong balance sheet and steady financial performance supported excellent or stable ratings from credit agencies, including Highmark Inc.'s A+ issuer credit rating from AM Best, Standard & Poor's affirmation of an "A" financial strength rating, and Moody’s "Baa1" (or stable outlook) rating.
Emily Gauthier
Highmark Health
412-544-8245
Email Emily
Sharing a deeply personal pandemic experience, our CFO celebrates the strength and perseverance that carry us forward.
Highmark Health's financials are regularly featured in regional and national publications and other media outlets.
Get insights from leaders creating a remarkable health experience.